PSMA PET reveals bone metastases missed by standard imaging

Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients, a critical indicator of a patient's long-term survival. Outcomes data revealed that patients with even just one bone metastasis experience faster disease progression and worse overall survival.